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Abstract
Background: Atrial Fibrillation is highly prevalent in clinical practice affecting approximately 2.3 million people in
USA and 4.5 million people in European Union. The aim of the study was to examine the association between nut
consumption and incident atrial fibrillation.
Methods: Prospective cohort of 21,054 male participants of Physicians’ Health Study I. Nut consumption was
estimated using food frequency questionnaire and incident atrial fibrillation was ascertained through yearly follow-
up questionnaires. Cox regression was used to estimate relative risks of atrial fibrillation.
Results: The average age was 54.6 ± 9.5 years (40.7-87.1). During a mean follow up of 20 years (median 24 years),
3,317 cases of atrial fibrillation occurred. The crude incidence rate was 7.6, 7.4, 8.2, 7.9, and 6.8 cases/1000 person-
years for people reporting nut consumption of rarely/never, 1-3/month, 1/per week, 2-6/week, and ≥ 7/week,
respectively. Multivariable adjusted hazard ratios (95% CI) for incident atrial fibrillation were 1.00 (ref), 1.00 (0.90-
1.11), 1.09 (0.97-1.21), 1.07 (0.95-1.21), and 0.91 (0.70-1.17) for nut consumption from the lowest to the highest
category of nut consumption (p for trend 0.26). No statistically significant association between nut consumption
and atrial fibrillation was found when stratified by body mass index (BMI < 25 vs ≥ 25 kg/m
2) or age (< 65 vs. ≥ 65
years).
Conclusions: Our data did not show an association between nut consumption and incident atrial fibrillation
among US male physicians.
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Background
Atrial Fibrillation (AF) is highly prevalent in clinical
practice affecting approximately 2.3 million people in
USA and 4.5 million people in European Union [1,2].
The incidence of AF increases by about 0.1%-0.2% per
year after the age of 40 while AF prevalence ranges
from 2%-4% in people over 60 years of age to 8% in
people over 80 years of age [3-6]. Prevalence for age-
adjusted AF is reported to be higher in men than in
women [4,7]. AF is associated with 2-7 fold increased
risk of ischemic stroke [8-11] and is also associated with
a higher rate of mortality [7,10,11]. Several risk factors
of AF have been shown to be influenced by modifiable
lifestyle factors. Among dietary factors, nuts are low in
sodium and contain many important nutrients including
mono- and polyunsaturated fatty acids, fiber, vitamins E,
and B2 (riboflavin), folate, and essential minerals (mag-
nesium, phosphorus, copper, selenium, and potassium),
thereby making them an excellent nutrient source [12].
Nut consumption has previously been associated with
improved serum cholesterol [13], blood pressure [14],
weight loss [15], risk of diabetes [16] and sudden death/
coronary heart disease [17]. Nuts are relatively cheap
and widely available and thereby can serve as a cost-
effective means to prevent AF. However, it is not known
whether nut consumption is associated with the risk of
incident AF. Therefore, the current study sought to pro-
spectively assess whether nut consumption is associated
with a lower risk of developing AF among US male
physicians.
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Study population
D a t aw a so b t a i n e df r o mt h eP h y s i c i a n s ’ Health Study
(PHS) I cohort. The details of the PHS I have been
described elsewhere [18]. In short, PHS I was a rando-
mized, double blind, placebo controlled trial, of 22,071 US
male physicians 40-84 years of age with no history of myo-
cardial infarction, stroke, transient ischemic events or can-
cer at the time of randomization, with a two-by-two
factorial design to study the effects of low dose aspirin
(ASA) and beta-carotene on cardiovascular disease and
cancer among the US male physicians (1982 to 1995). Of
the 22,071 subjects in the PHS, we excluded subjects who
were lost to follow up (n = 7) at 12 month post-randomi-
zation, those with missing data on nut consumption (n =
612), and those with prevalent AF (n = 398) at 12 months
post-randomization. Thus, a final sample of 21,054 partici-
pants was selected for current analyses.
Information on health status, risk factors for cardiovas-
cular disease (CVD), dietary, and lifestyle factors was col-
lected by questionnaires. Each participant gave written
informed consent and the Institutional Review Board at
Brigham and Women’s Hospital approved the study
protocol.
Nut consumption
Information on nut consumption was self-reported using a
simple abbreviated food frequency questionnaire at 12
months post-randomization (1983-1985). Participants
were asked the following: “Please indicate how often, on
average, you have eaten each of the following foods during
the past year”. “Nuts (small packet or 1 oz.)” Possible
response categories included “rarely/never”, “1-3/month”,
“1/week”, “2-4/week”, “5-6/week”, “daily”,a n d“2+/day”.
While the food frequency questionnaire was not validated
in the Physicians’ Health Study, it has been validated in
several cohorts [19-21].
Primary outcome
Primary outcome was the development of AF in the
study population. As presented in the ACC/AHA ESC
guidelines for the management of patients with first
detected episode of AF it can be classified into: Paroxys-
mal (self terminating usually lasting < 7 days) and Per-
sistent (non- self terminating usually lasting > 7 days).
Recurrent if two or more episodes of AF and permanent
AF if Persistent AF is long lasting [1]. All types of AF
cases were assessed annually via follow-up question-
naires from 12 months forward. These self- reports of
AF have been validated in another study conducted in
the same cohort using a more detailed questionnaire on
the diagnosis of AF and the review of medical records
[22].
Other variables
Data on demographics, anthropometrics, randomization
to ASA, randomization to beta-carotene, diabetes melli-
tus (DM), hypertension (HTN), hypercholesterolemia,
coronary heart disease (CHD), congestive heart failure
(CHF) physical activity, smoking as well as cereal, fruit,
vegetable, and alcohol consumption were assessed at the
baseline (1982-1983). Age was categorized in 5 year cate-
gories (< 45, 45-49, 50-54, 55-59, 60-64, 65-69, 70-74,
and 75+ y), body mass index (BMI) was classified as lean,
overweight, and obese i.e. < 25, 25-29.9, and ≥ 30 kg/m
2,
respectively. Randomization to both ASA and beta-caro-
tene was categorized as yes versus no. For physical activ-
ity, participants were asked how often they exercised to
sweat; for current analysis, physical activity was dichoto-
m i z e di n t oe x e r c i s et os w e a t≥ 1 versus < 1 per week.
Smoking was classified as never, past, and current smo-
kers. Alcohol consumption was classified as none,
monthly, weekly, and daily. Cereal consumption was clas-
sified as ≤ 1, 2-6, and ≥ 7 servings per week. Fruit/vegeta-
ble consumption was categorized as servings per week
and used as a continuous variable. Diagnosis of DM was
made on self-reports via questionnaires mailed to each
participant every 6 months during the first year and
annually thereafter. HTN was defined as anyone who self
reported the diagnosis, BP > 140/90 mm Hg per JNC7
guidelines or on the basis of medication list provided by
the study participants. Diagnosis of hypercholesterolemia
was also made on self-report as well as on the basis of
available blood cholesterol levels. Diagnosis of CHD was
made by including patients with self reported history of
myocardial infarction (MI) and coronary artery bypass
grafting (CABG). CHF diagnosis was again self reported
and was verified and validated by detailed review of the
medical record [23].
Statistical analysis
We classified each subject into one of the following cate-
gories of nut consumption: rarely/never, 1-3 per month,
1 per week, 2-6 per week, and 7+ per week as described
previously in this cohort [36, 37]. We computed person-
time of follow up from exposure assessment (12 months
post-randomization) until the first occurrence of a) AF,
b) death, or c) censoring date i.e. the date of last available
follow up. Baseline demographic variables were recorded
and compared with respect to each category of nut
consumption.
We used Cox proportional hazard models to compute
multivariable adjusted hazard ratios (HR) with corre-
sponding 95% confidence intervals (CI) using partici-
pants in the lowest category of nut consumption as the
reference group. Potential confounding was assessed for
established risk factors of AF. The basic model only
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multivariable model and controlled for age in 5-year
categories, BMI randomization to ASA, randomization to
beta-carotene, physical activity, smoking, cereal consump-
tion, fruit/vegetable consumption, alcohol consumption,
history of HTN, history of hypercholesterolemia, and DM.
In a secondary analysis using BMI of 25 kg/m
2 as cut
point, we assessed if adiposity modified the relation
between nut consumption and AF. We then conducted
stratified analyses by BMI < 25 or ≥ 25 kg/m
2 and tested
statistical interaction using a product term of nut con-
sumption and adiposity variable in a hierarchical model.
We also conducted stratified analyses by age using 65
years as cut point to assess if aging modified the relation
between nut consumption and AF.
Since information on nut exposure does not describe
peanut butter, a relatively large source across the U.S. it
was separately queried using the same multivariable model
as for nut consumption. We classified each subject into
one of the following categories of peanut butter consump-
tion: None, 1-3 per month, 1 per week, 2-6 per week, and
7+ per week. In an additional analysis using the same mul-
tivariable model we dichotomized nut consumption into ≥
weekly versus < weekly to see if it modified the relation
between nut consumption and AF.
A sensitivity analysis by excluding those who developed
any chronic disease such as any cancer, DM, or CVD and
consequently might have changed their dietary patterns
during the follow-up was also conducted. Assumptions for
proportional hazard models were tested (by including
main effects and product terms of nut consumption and
logarithmic-transformed time factor) and were met (all P
values > 0.05). All analyses were conducted using SAS,
version 9.2 (SAS Institute, NC). Significance level was set
at 0.05.
Results
Table 1 shows the baseline demographics of 21,054 US
male according to the categories of nut consumption.
Mean age of the study participants was 54.6 ± 9.5 years
(range 40.7 to 87.1 years). Among the total participants
reporting nut consumption, there were 20%, 36%, 24%,
17%, and 3% people in the rarely/never, 1-3 per month,
1 per week, 2-6 per week, and ≥ 7 per week categories
respectively. Frequent nut consumption was associated
with a lower prevalence of current smoking and HTN
while a higher prevalence of physical activity, fruit/vegeta-
ble intake, and cereal intake. During an average follow up
of 20 years (median 24 years), 3,317 new cases of AF were
reported. The crude incidence rates of AF were 7.6, 7.4,
8.2, 7.9, and 6.8 cases/1,000 person-years, from the lowest
to the highest category of nut consumption (Table 2).
There was no statistically significant association between
nut consumption and incident AF. Multivariable adjusted
hazard ratios (95% CI) for incident AF were 1.00 (ref), 1.00
(0.90-1.11), 1.09 (0.97-1.21), 1.07 (0.95-1.21), and 0.91
(0.70-1.17) for nut consumption of rarely/never, 1-3 per
month, 1 per week, 2-6 per week, and ≥ 7 per week with p
for linear trend of 0.26 (Table 2).
In a secondary analysis, nut consumption was not
associated with incident AF among lean subjects (BMI <
25 kg/m
2) [multivariable adjusted hazard ratios (95% CI)
of 1.0 (reference), 1.07 (0.92-1.23), 1.16 (0.99-1.36), 1.16
(0.98-1.37), and 0.97 (0.70-1.34) from the lowest to the
highest category of nut consumption, respectively (p for
trend 0.11)]. Corresponding values for individuals that
were overweight/obese were 1.0 (reference), 0.95 (0.82-
1.09), 1.02 (0.87-1.19), 0.98 (0.82-1.18), and 0.84 (0.54-
1.29), respectively (p for trend 0.95)].
Similarly, nut consumption was not associated with
incident AF among younger (age < 65 years) physicians
[multivariable adjusted hazard ratios (95% CI) of 1.0
(reference), 0.99 (0.88-1.11), 1.06 (0.94-1.20), 1.07 (0.94-
1.23), and 0.92 (0.69-1.22) across consecutive categories
of nut consumption, respectively (p for trend 0.30)].
Corresponding values for older participants (≥ 65 y)
were 1.0 (reference), 1.06 (0.84-1.34), 1.20 (0.93-1.53),
1.04 (0.78-1.37), and 0.88 (0.48-1.60), respectively (p for
trend 0.71)].
In a separate analysis multivariable adjusted hazard
ratios (95% CI) for incident AF for peanut butter con-
sumption were 1.00 (ref), 1.01 (0.91-1.11), 1.13 (1.02-
1.25), 1.01 (0.90-1.12), and 1.00 (0.80-1.25) from the
lowest to the highest category, respectively (overall p =
0.41). The multivariable adjusted hazard ratios (95% CI)
for incident AF using nut consumption as ≥ weekly ver-
sus < weekly was 1.07 (0.99-1.15).
Results of sensitivity analysis excluding those who
developed any chronic disease such as any cancer, DM,
or CVD did not alter the results either [hazard ratios
(95% CI) of 1.0 (reference), 1.00 (0.89-1.14), 1.07 (0.94-
1.23), 1.10 (0.95-1.27), and 0.94 (0.70-1.26) from the
lowest to the highest category of nut consumption,
respectively, p for trend 0.22].
Discussion
Our findings do not support a meaningful association
between the consumption of nuts and incident AF
among apparently healthy US male physicians. In addi-
tion, adiposity or advancing age did not modify the rela-
tion between nut intake and AF risk. To the best of our
knowledge, this is the first large prospective study to
assess the association between nut consumption and the
incidence of AF.
Several factors could have lead to this null association
between nut consumption and incident AF. We did not
have any data on the type of nuts consumed. We were
also unable to characterize different types of nut
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on the incident AF. Perhaps in 1980s, nut intake was not
necessarily low in sodium and this could have lead to a
higher prevalence of HTN, an important risk factor for
AF. However, lower prevalence of HTN with increased
nut consumption argues against it as a possible explana-
tion. Each of the different types of nut (i.e. walnut, pista-
chio, hazelnut, etc) has been demonstrated to have a
specific nutrient profile. Another important limitation was
a single assessment of nut consumption during the study
period. The results indicate that although the power was
limited at the levels of nut consumption that would be
most likely to influence AF risk, there was a non-statisti-
cally significant increase in AF risk among all consumers
of nuts weekly or more. As a post hoc analysis, this would
therefore be an interesting analysis for other data sets. We
did not have information on family history of hyperten-
sion, hypercholesterolemia, or diabetes and therefore were
Table 1 Baseline characteristic of 21,054 US male physicians according to nut consumption
Variables Categories of nut consumption
Rarely/Never
N = 4,273
1-3/month
N = 7,654
1/week
N = 4,965
2-6/week
N = 3,617
≥ 7/week
N = 545
Age (years) 55.4 ± 9.9 54.3 ± 9.4 54.3 ± 9.3 54.5 ± 9.3 55.9 ± 9.8
Body mass index (kg/m
2) 24.8 ± 2.9 24.8 ± 2.8 24.9 ± 2.8 24.7 ± 2.6 24.1 ± 2.5
Randomized to ASA (%) 50.4 49.9 49.2 50.6 50.6
Randomized to Beta-Carotene (%) 50.6 49.9 50.2 49.2 50.5
Hypercholesterolemia (%) 12.4 11.6 12.2 12.0 12.6
Hypertension (%) 26.3 23.9 22.9 21.4 19.0
Physical activity 67.2 71.9 74.6 75.5 77.1
[exercise to sweat ≥ 1 per week] (%)
Current smokers (%) 12.4 10.9 10.5 10.4 11.8
Cereal intake [servings per week]
(%)
≤ 1 59.5 55.1 51.6 50.8 50.6
2-6 19.9 23.9 26.5 27.0 18.5
≥ 7 20.6 20.9 22.0 22.2 30.8
Fruit/vegetable (servings/week) 16.4 ± 9.0 16.4 ± 8.6 16.9 ± 8.4 17.4 ± 8.4 18.8 ± 10.8
Peanut butter consumption (%)
Rarely/Never 65.0 39.8 27.3 27.0 33.0
1-3/month 14.5 31.4 23.9 18.2 22.7
1/week 8.9 13.8 27.5 19.8 14.6
2-6/week 9.3 12.5 19.0 30.8 15.7
≥ 7/week 2.3 2.5 2.4 4.3 14.0
Current drinking (%) 83.0 86.0 86.0 85.0 80.7
Diabetes mellitus (%) 3.7 2.9 2.9 3.6 5.9
Congestive heart failure (%) 0.2 0.1 0.1 0.1 0.0
Coronary heart disease (%) 1.5 1.0 1.0 0.9 0.6
Data are presented as mean ± standard deviation or percentages
Table 2 Hazard ratios (95% CI) for atrial fibrillation according to nut consumption in Physicians’ Health Study
Nut intake Cases/person- years Crude incidence rate (1,000 person-years) Hazards Ratio (95% Confidence Interval)
Unadjusted Age adjusted* Model 1**
Rarely/Never 644/84926 7.6 1.0 1.0 1.0
1-3/month 1170/157704 7.4 0.97 (0.88 - 1.06) 1.01 (0.92 - 1.12) 1.00 (0.90 - 1.11)
1/week 842/102290 8.2 1.07 (0.97 - 1.19) 1.12 (1.01 - 1.24) 1.09 (0.97 - 1.21)
2-6/week 587/74642 7.9 1.03 (0.92 - 1.15) 1.05 (0.94 - 1.18) 1.07 (0.95 - 1.21)
≥ 7/week 74/10865 6.8 0.90 (0.71 - 1.14) 0.88 (0.69 - 1.12) 0.91 (0.70 - 1.17)
P for trend 0.41 0.33 0.26
*Age as ordinal variable Adjusted for age (< 45, 45-49, 50-54, 55-59, 60-64, 65-69, 70-74, 75+ y)
**Adjusted for Age (< 45, 45-49, 50-54, 55-59, 60-64, 65-69, 70-74, 75+ y), body mass index (< 25, 25-29.9, and 30+ kg/m
2), aspirin, beta-carotene, physical activity
(1 or more times per week vs. < 1 per week), smoking (never, past and current smokers), cereal servings per week (≤ 1, 2-6, ≥ 7), fruit/vegetable servings per
week (continuous), alcohol consumption (none, monthly, weekly, daily), history of hypertension, history of hypercholesterolemia and history of diabetes
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activity was also a potential limitation in our analysis and
could have lead to residual confounding. Lastly our popu-
lation consisted of only male physicians, who might have a
higher consumption of nuts due to being aware of their
health benefits making it difficult to generalize our find-
ings to the general population.
D e s p i t eal a c ko fa s s o c i a t i o nb e t w e e nn u tc o n s u m p -
tion and AF, beneficial effects of nuts have been
reported on numerous outcomes considered to be
important risk factors for developing AF. Nuts have
been shown to improve serum cholesterol levels [13],
lower blood pressure [14,24-28], lower the risk of DM
[16], improve weight loss [15], improve inflammation
[29], and lower the risk of cardiovascular mortality [17].
Our study has several strengths, including a large sam-
ple size, 20 years follow up, use of a standardized ques-
tionnaires, and a homogeneous group of male
physicians able to recognize signs and symptoms of AF
than the general population.
Conclusion
In summary, our study does not provide evidence in
support of a significant association between nut con-
sumption and incident AF among US male physicians.
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